Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 372 articles:
HTML format



Single Articles


    May 2020
  1. SAVOLDI A, Carrara E, Tacconelli E
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list-authors' response.
    J Antimicrob Chemother. 2020 May 27. pii: 5847827. doi: 10.1093.
    PubMed    


  2. LAM TT, Nurnberg S, Claus H, Vogel U, et al
    Molecular epidemiology of imipenem resistance in invasive Haemophilus influenzae infections in Germany in 2016.
    J Antimicrob Chemother. 2020 May 25. pii: 5843865. doi: 10.1093.
    PubMed     Abstract available


  3. MUGGEO A, Cambau E, Amara M, Micaelo M, et al
    Phenotypic and genotypic quinolone resistance in Escherichia coli underlining GyrA83/87 mutations as a target to detect ciprofloxacin resistance.
    J Antimicrob Chemother. 2020 May 22. pii: 5842234. doi: 10.1093.
    PubMed     Abstract available


  4. RAWSON TM, Moore LSP, Castro-Sanchez E, Charani E, et al
    COVID-19 and the potential long-term impact on antimicrobial resistance.
    J Antimicrob Chemother. 2020 May 20. pii: 5841159. doi: 10.1093.
    PubMed     Abstract available


  5. ORTIZ-PADILLA M, Diaz-Diaz S, Machuca J, Tejada-Gonzalez A, et al
    Role of low-level quinolone resistance in generating tolerance in Escherichia coli under therapeutic concentrations of ciprofloxacin.
    J Antimicrob Chemother. 2020 May 19. pii: 5836071. doi: 10.1093.
    PubMed     Abstract available


  6. DE LASTOURS V, Laouenan C, Royer G, Carbonnelle E, et al
    Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    J Antimicrob Chemother. 2020 May 17. pii: 5838343. doi: 10.1093.
    PubMed     Abstract available


  7. MARTINEZ EP, van Rosmalen J, Bustillos R, Natsch S, et al
    Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    J Antimicrob Chemother. 2020 May 17. pii: 5838345. doi: 10.1093.
    PubMed     Abstract available


  8. EICHEL V, Klein S, Bootsveld C, Frank U, et al
    Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.
    J Antimicrob Chemother. 2020 May 15. pii: 5837672. doi: 10.1093.
    PubMed     Abstract available


  9. VAN GAALEN RD, Altorf-van der Kuil W, Wegdam-Blans MCA, Aguilar Diaz JM, et al
    Determination of the time-dependent association between ciprofloxacin consumption and ciprofloxacin resistance using a weighted cumulative exposure model compared with standard models.
    J Antimicrob Chemother. 2020 May 14. pii: 5837067. doi: 10.1093.
    PubMed     Abstract available


  10. LI LH, Wu CM, Lin YT, Pan SY, et al
    Roles of FadRACB system in formaldehyde detoxification, oxidative stress alleviation and antibiotic susceptibility in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2020 May 14. pii: 5837066. doi: 10.1093.
    PubMed     Abstract available


  11. CHANAME PINEDO LE, Bruyndonckx R, Catry B, Latour K, et al
    Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study.
    J Antimicrob Chemother. 2020 May 12. pii: 5836063. doi: 10.1093.
    PubMed     Abstract available


  12. MANOHARAN A, Das T, Whiteley GS, Glasbey T, et al
    The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2020 May 3. pii: 5828489. doi: 10.1093.
    PubMed     Abstract available


  13. DELORY T, Jeanmougin P, Lariven S, Aubert JP, et al
    A computerized decision support system (CDSS) for antibiotic prescription in primary care-Antibioclic: implementation, adoption and sustainable use in the era of extended antimicrobial resistance.
    J Antimicrob Chemother. 2020 May 1. pii: 5827803. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  14. TORUMKUNEY D, Tunger A, Sancak B, Bicakcigil A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  15. TORUMKUNEY D, Van PH, Thinh LQ, Koo SH, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  16. TORUMKUNEY D, Bratus E, Yuvko O, Pertseva T, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  17. TORUMKUNEY D, Hammami A, Mezghani Maalej S, Ayed NB, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-18 in Tunisia, Kenya and Morocco: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  18. TORUMKUNEY D, Anwar S, Nizamuddin S, Malik N, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  19. TORUMKUNEY D, Smayevsky J, Relloso MS, Sucari A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  20. TORUMKUNEY D, Mokaddas E, Jiman-Fatani A, Ageel A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


    March 2020
  21. ROHDE AM, Zweigner J, Wiese-Posselt M, Schwab F, et al
    Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals.
    J Antimicrob Chemother. 2020 Mar 16. pii: 5805542. doi: 10.1093.
    PubMed     Abstract available


  22. CAMPBELL AJ, Daley DA, Bell JM, Pang S, et al
    Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programme: Staphylococcus aureus, enterococcal and Gram-negative bacteraemia in Australia.
    J Antimicrob Chemother. 2020 Mar 10. pii: 5802603. doi: 10.1093.
    PubMed     Abstract available


  23. RUBIN IMC, Pedersen MS, Mollerup S, Kaya H, et al
    Association between vancomycin-resistant Enterococcus faecium colonization and subsequent infection: a retrospective WGS study.
    J Antimicrob Chemother. 2020 Mar 3. pii: 5775585. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  24. KON H, Abramov S, Amar Ben Dalak M, Elmaliach N, et al
    Performance of Rapid Polymyxin NP and Rapid Polymyxin Acinetobacter for the detection of polymyxin resistance in carbapenem-resistant Acinetobacter baumannii and Enterobacterales.
    J Antimicrob Chemother. 2020 Feb 28. pii: 5766089. doi: 10.1093.
    PubMed     Abstract available


  25. EISENBERGER D, Tuschak C, Werner M, Bogdan C, et al
    Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany.
    J Antimicrob Chemother. 2020 Feb 21. pii: 5743460. doi: 10.1093.
    PubMed     Abstract available


  26. WANG N, Zhou Y, Zhang H, Liu Y, et al
    In vitro activities of acetylmidecamycin and other antimicrobials against human macrolide-resistant Mycoplasma pneumoniae isolates.
    J Antimicrob Chemother. 2020 Feb 19. pii: 5740615. doi: 10.1093.
    PubMed     Abstract available


  27. LAN PT, Golparian D, Ringlander J, Van Hung L, et al
    Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16.
    J Antimicrob Chemother. 2020 Feb 18. pii: 5740025. doi: 10.1093.
    PubMed     Abstract available


  28. BOURELY C, Coeffic T, Caillon J, Thibaut S, et al
    Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals.
    J Antimicrob Chemother. 2020 Feb 12. pii: 5734707. doi: 10.1093.
    PubMed     Abstract available


  29. KUMAR N, Raven KE, Blane B, Leek D, et al
    Evaluation of a fully automated bioinformatics tool to predict antibiotic resistance from MRSA genomes.
    J Antimicrob Chemother. 2020 Feb 5. pii: 5727893. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  30. AARESTRUP FM, van Bunnik B
    Comment on: Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    J Antimicrob Chemother. 2020 Jan 23. pii: 5714832. doi: 10.1093.
    PubMed    


  31. MAJEWSKI P, Gutowska A, Sacha P, Schneiders T, et al
    Expression of AraC/XylS stress response regulators in two distinct carbapenem-resistant Enterobacter cloacae ST89 biotypes.
    J Antimicrob Chemother. 2020 Jan 20. pii: 5710711. doi: 10.1093.
    PubMed     Abstract available


  32. GIANI T, Antonelli A, Sennati S, Di Pilato V, et al
    Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): activity of ceftazidime/avibactam against Enterobacterales isolated from urine.
    J Antimicrob Chemother. 2020 Jan 20. pii: 5709880. doi: 10.1093.
    PubMed     Abstract available


  33. PAINSET A, Day M, Doumith M, Rigby J, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015-16.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707358. doi: 10.1093.
    PubMed     Abstract available


  34. ROGERS VAN KATWYK S, Grimshaw JM, Nkangu M, Mendelson M, et al
    Study reporting quality among interventions to reduce antibiotic use is a barrier to evidence-informed policymaking on antimicrobial resistance: systematic review.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707357. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  35. SHEN WJ, Deshpande A, Hevener KE, Endres BT, et al
    Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.
    J Antimicrob Chemother. 2019 Dec 24. pii: 5686405. doi: 10.1093.
    PubMed     Abstract available


  36. WEGENER A, Damborg P, Guardabassi L, Moodley A, et al
    Specific staphylococcal cassette chromosome mec (SCCmec) types and clonal complexes are associated with low-level amoxicillin/clavulanic acid and cefalotin resistance in methicillin-resistant Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2019 Dec 17. pii: 5679833. doi: 10.1093.
    PubMed     Abstract available


  37. LO SW, Gladstone RA, van Tonder AJ, Du Plessis M, et al
    A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650366. doi: 10.1093.
    PubMed     Abstract available


  38. HAYAKAWA K, Nakano R, Hase R, Shimatani M, et al
    Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650359. doi: 10.1093.
    PubMed     Abstract available


  39. SAVOLDI A, Carrara E, Gladstone BP, Azzini AM, et al
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    J Antimicrob Chemother. 2019;74:3619-3625.
    PubMed     Abstract available


    November 2019
  40. ESPINOSA-GONGORA C, Jessen LR, Kieler IN, Damborg P, et al
    Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and beta-lactam resistance in the canine faecal microbiota.
    J Antimicrob Chemother. 2019 Nov 28. pii: 5645151. doi: 10.1093.
    PubMed     Abstract available


  41. SUN L, Chen Y, Hua X, Chen Y, et al
    Tandem amplification of the vanM gene cluster drives vancomycin resistance in vancomycin-variable enterococci.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632032. doi: 10.1093.
    PubMed     Abstract available


  42. LESTER R, Musicha P, van Ginneken N, Dramowski A, et al
    Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632029. doi: 10.1093.
    PubMed     Abstract available


  43. ZHANG Y, Jin L, Ouyang P, Wang Q, et al
    Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
    J Antimicrob Chemother. 2019 Nov 12. pii: 5622907. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  44. BRITTO CD, Dyson ZA, Mathias S, Bosco A, et al
    Persistent circulation of a fluoroquinolone-resistant Salmonella enterica Typhi clone in the Indian subcontinent.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607520. doi: 10.1093.
    PubMed     Abstract available


  45. JAHAN MI, Rahaman MM, Hossain MA, Sultana M, et al
    Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of beta-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
    J Antimicrob Chemother. 2019 Oct 24. pii: 5606763. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  46. ANTONELLI A, Giani T, Coppi M, Di Pilato V, et al
    Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
    J Antimicrob Chemother. 2019 Sep 6. pii: 5563998. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  47. EIGENBROD T, Reuter S, Gross A, Kocer K, et al
    Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15.
    J Antimicrob Chemother. 2019 Aug 31. pii: 5557811. doi: 10.1093.
    PubMed     Abstract available


  48. COOMBS GW, Mowlaboccus S, Daley D, Lee T, et al
    Sulfamethoxazole/trimethoprim resistance overcall by VITEK(R) 2 and BD Phoenix in community-associated MRSA and MSSA.
    J Antimicrob Chemother. 2019 Aug 20. pii: 5552317. doi: 10.1093.
    PubMed    


  49. LAGACE-WIENS PRS, Adam HJ, Poutanen S, Baxter MR, et al
    Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


  50. GOLDEN AR, Baxter MR, Davidson RJ, Martin I, et al
    Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


  51. MCCRACKEN MG, Adam HJ, Blondeau JM, Walkty AJ, et al
    Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


    July 2019
  52. LIAO X, Yang RS, Xia J, Chen L, et al
    High colonization rate of a novel carbapenem-resistant Klebsiella lineage among migratory birds at Qinghai Lake, China.
    J Antimicrob Chemother. 2019 Jul 24. pii: 5538005. doi: 10.1093.
    PubMed     Abstract available


  53. PITT R, Sadouki Z, Town K, Fifer H, et al
    Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2019;74:2115-2116.
    PubMed    


    June 2019
  54. CHANCHAITHONG P, Perreten V, Schwendener S
    Macrococcus canis contains recombinogenic methicillin resistance elements and the mecB plasmid found in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523695. doi: 10.1093.
    PubMed     Abstract available


  55. LUNA BM, Ershova K, Yan J, Ulhaq A, et al
    Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.
    J Antimicrob Chemother. 2019 Jun 6. pii: 5512099. doi: 10.1093.
    PubMed     Abstract available


  56. HANRAHAN JK, Hogan TR, Buckley C, Trembizki E, et al
    Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history.
    J Antimicrob Chemother. 2019 Jun 6. pii: 5512101. doi: 10.1093.
    PubMed     Abstract available


  57. CUSACK TP, Phimolsarnnousith V, Duangmala K, Phoumin P, et al
    Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic.
    J Antimicrob Chemother. 2019 Jun 5. pii: 5511712. doi: 10.1093.
    PubMed    


    May 2019
  58. CHANG SC, Lin LC, Ge MC, Liu TP, et al
    Characterization of a novel, type II staphylococcal cassette chromosome mec element from an endemic oxacillin-resistant Staphylococcus lugdunensis clone in a hospital setting.
    J Antimicrob Chemother. 2019 May 18. pii: 5491489. doi: 10.1093.
    PubMed     Abstract available


  59. LEI CW, Kang ZZ, Wu SK, Chen YP, et al
    Detection of the phenicol-oxazolidinone-tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China.
    J Antimicrob Chemother. 2019 May 18. pii: 5491555. doi: 10.1093.
    PubMed    


  60. LLORENS-VILLAR Y, Tusell F, Canut A, Barrasa H, et al
    Antibiotic susceptibility trend before and after long-term use of selective digestive decontamination: a 16 year ecological study.
    J Antimicrob Chemother. 2019 May 7. pii: 5486502. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  61. AMBROSE SJ, Hall RM
    Novel trimethoprim resistance gene, dfrA35, in IncC plasmids from Australia.
    J Antimicrob Chemother. 2019 Apr 15. pii: 5464311. doi: 10.1093.
    PubMed     Abstract available


  62. ROONEY CM, Sheppard AE, Clark E, Davies K, et al
    Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon.
    J Antimicrob Chemother. 2019 Apr 15. pii: 5464308. doi: 10.1093.
    PubMed     Abstract available


  63. DEL BARRIO-TOFINO E, Zamorano L, Cortes-Lara S, Lopez-Causape C, et al
    Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
    J Antimicrob Chemother. 2019 Apr 15. pii: 5464315. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  64. PINHOLT M, Bayliss SC, Gumpert H, Worning P, et al
    WGS of 1058 Enterococcus faecium from Copenhagen, Denmark, reveals rapid clonal expansion of vancomycin-resistant clone ST80 combined with widespread dissemination of a vanA-containing plasmid and acquisition of a heterogeneous accessory genome.
    J Antimicrob Chemother. 2019 Mar 30. pii: 5423852. doi: 10.1093.
    PubMed     Abstract available


  65. VAN HECKE O, Butler CC, Wang K, Tonkin-Crine S, et al
    Parents' perceptions of antibiotic use and antibiotic resistance (PAUSE): a qualitative interview study.
    J Antimicrob Chemother. 2019 Mar 16. pii: 5382160. doi: 10.1093.
    PubMed     Abstract available


  66. TIETGEN M, Kramer JS, Brunst S, Djahanschiri B, et al
    Identification of the novel class D beta-lactamase OXA-679 involved in carbapenem resistance in Acinetobacter calcoaceticus.
    J Antimicrob Chemother. 2019 Mar 7. pii: 5371188. doi: 10.1093.
    PubMed     Abstract available


  67. KUMBURU HH, Sonda T, van Zwetselaar M, Leekitcharoenphon P, et al
    Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania.
    J Antimicrob Chemother. 2019 Mar 6. pii: 5370329. doi: 10.1093.
    PubMed     Abstract available


  68. JIAN MJ, Cheng YH, Chung HY, Cheng YH, et al
    Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis.
    J Antimicrob Chemother. 2019 Mar 4. pii: 5369197. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  69. GIANECINI RA, Golparian D, Zittermann S, Litvik A, et al
    Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16.
    J Antimicrob Chemother. 2019 Feb 28. pii: 5366949. doi: 10.1093.
    PubMed     Abstract available


  70. HE DD, Zhao SY, Wu H, Hu GZ, et al
    Antimicrobial resistance-encoding plasmid clusters with heterogeneous MDR regions driven by IS26 in a single Escherichia coli isolate.
    J Antimicrob Chemother. 2019 Feb 28. pii: 5366961. doi: 10.1093.
    PubMed     Abstract available


  71. MEUNIER A, Nerich V, Fagnoni-Legat C, Richard M, et al
    Enhanced emergence of antibiotic-resistant pathogenic bacteria after in vitro induction with cancer chemotherapy drugs.
    J Antimicrob Chemother. 2019 Feb 20. pii: 5353166. doi: 10.1093.
    PubMed     Abstract available


  72. BA X, Kalmar L, Hadjirin NF, Kerschner H, et al
    Truncation of GdpP mediates beta-lactam resistance in clinical isolates of Staphylococcus aureus.
    J Antimicrob Chemother. 2019 Feb 12. pii: 5316432. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  73. FERNANDEZ-ORTH D, Miro E, Brown-Jaque M, Rodriguez-Rubio L, et al
    Faecal phageome of healthy individuals: presence of antibiotic resistance genes and variations caused by ciprofloxacin treatment.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288153. doi: 10.1093.
    PubMed     Abstract available


  74. JUHAS M, Widlake E, Teo J, Huseby DL, et al
    In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    J Antimicrob Chemother. 2019 Jan 9. pii: 5284660. doi: 10.1093.
    PubMed     Abstract available


  75. DE JONG A, Simjee S, Rose M, Moyaert H, et al
    Antimicrobial resistance monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 2004-14 (EASSA Study).
    J Antimicrob Chemother. 2019 Jan 8. pii: 5280942. doi: 10.1093.
    PubMed     Abstract available


  76. WHITNEY L, Al-Ghusein H, Glass S, Koh M, et al
    Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010-16.
    J Antimicrob Chemother. 2019;74:234-241.
    PubMed     Abstract available


  77. YU Y, Walsh TR, Yang RS, Zheng M, et al
    Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model.
    J Antimicrob Chemother. 2019;74:87-95.
    PubMed     Abstract available


  78. YAN J, Xue J, Chen Y, Chen S, et al
    Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17).
    J Antimicrob Chemother. 2019;74:29-37.
    PubMed     Abstract available


  79. SO W, Shurko J, Galega R, Quilitz R, et al
    Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin.
    J Antimicrob Chemother. 2019;74:269-271.
    PubMed    


  80. KEITA A, Sereme Y, Pillet S, Coulibaly S, et al
    Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali.
    J Antimicrob Chemother. 2019;74:165-171.
    PubMed     Abstract available


  81. HIRSCH R, Wiesner J, Marker A, Pfeifer Y, et al
    Profiling antimicrobial peptides from the medical maggot Lucilia sericata as potential antibiotics for MDR Gram-negative bacteria.
    J Antimicrob Chemother. 2019;74:96-107.
    PubMed     Abstract available


  82. CHAPLIN B, Akanmu AS, Inzaule SC, Samuels JO, et al
    Association between HIV-1 subtype and drug resistance in Nigerian infants.
    J Antimicrob Chemother. 2019;74:172-176.
    PubMed     Abstract available


  83. GAUTHIER L, Dortet L, Jousset AB, Mihaila L, et al
    Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae.
    J Antimicrob Chemother. 2019;74:42-47.
    PubMed     Abstract available


    December 2018
  84. VERNON JJ, Wilcox MH, Freeman J
    Effect of fluoroquinolone resistance mutation Thr-82-->Ile on Clostridioides difficile fitness.
    J Antimicrob Chemother. 2018 Dec 24. pii: 5260843. doi: 10.1093.
    PubMed     Abstract available


  85. LIU Z, Zhang R, Li W, Yang L, et al
    Amino acid changes at the VIM-48 C-terminus result in increased carbapenem resistance, enzyme activity and protein stability.
    J Antimicrob Chemother. 2018 Dec 22. pii: 5258053. doi: 10.1093.
    PubMed     Abstract available


  86. MACFADYEN AC, Harrison EM, Drigo I, Parkhill J, et al
    A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC.
    J Antimicrob Chemother. 2018 Dec 22. pii: 5258045. doi: 10.1093.
    PubMed     Abstract available


  87. ASHLEY EA, Shetty N, Patel J, van Doorn R, et al
    Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings.
    J Antimicrob Chemother. 2018 Dec 13. pii: 5245301. doi: 10.1093.
    PubMed     Abstract available


  88. MARQUES C, Menezes J, Belas A, Aboim C, et al
    Klebsiella pneumoniae causing urinary tract infections in companion animals and humans: population structure, antimicrobial resistance and virulence genes.
    J Antimicrob Chemother. 2018 Dec 10. pii: 5237779. doi: 10.1093.
    PubMed     Abstract available


  89. EILERTSON B
    CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City-author response.
    J Antimicrob Chemother. 2018 Dec 5. pii: 5231911. doi: 10.1093.
    PubMed    


  90. BRENCIANI A, Fioriti S, Morroni G, Cucco L, et al
    Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230877. doi: 10.1093.
    PubMed    


  91. ACCOCEBERRY I, Couzigou C, Fitton-Ouhabi V, Biteau N, et al
    Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230873. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  92. WYRES KL, Lam MMC, Holt KE
    Comment on: CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.
    J Antimicrob Chemother. 2018 Nov 30. pii: 5224781. doi: 10.1093.
    PubMed    


  93. PULCINI C, Clerc-Urmes I, Attinsounon CA, Fougnot S, et al
    Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study.
    J Antimicrob Chemother. 2018 Nov 30. pii: 5224777. doi: 10.1093.
    PubMed     Abstract available


  94. DENISUIK AJ, Garbutt LA, Golden AR, Adam HJ, et al
    Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
    J Antimicrob Chemother. 2018 Nov 29. pii: 5219007. doi: 10.1093.
    PubMed     Abstract available


  95. RAM M R, Teh X, Rajakumar T, Goh KL, et al
    Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.
    J Antimicrob Chemother. 2018 Nov 6. pii: 5162962. doi: 10.1093.
    PubMed     Abstract available


  96. SHERRARD LJ, Schaible B, Graham KA, McGrath SJ, et al
    Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.
    J Antimicrob Chemother. 2018;73:3218.
    PubMed    


    October 2018
  97. COPPRY M, Jeanne-Leroyer C, Noize P, Dumartin C, et al
    Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
    J Antimicrob Chemother. 2018 Oct 29. pii: 5146515. doi: 10.1093.
    PubMed     Abstract available


  98. LOPEZ B, Siqueira de Oliveira R, Pinhata JMW, Chimara E, et al
    Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    J Antimicrob Chemother. 2018 Oct 25. pii: 5144701. doi: 10.1093.
    PubMed     Abstract available


  99. HSUEH SC, Lee YJ, Huang YT, Liao CH, et al
    In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstr
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144002. doi: 10.1093.
    PubMed     Abstract available


  100. BROSH-NISSIMOV T, Navon-Venezia S, Keller N, Amit S, et al
    Risk analysis of antimicrobial resistance in outpatient urinary tract infections of young healthy adults.
    J Antimicrob Chemother. 2018 Oct 23. pii: 5144000. doi: 10.1093.
    PubMed     Abstract available


  101. RECACHA E, Machuca J, Diaz-Diaz S, Garcia-Duque A, et al
    Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.
    J Antimicrob Chemother. 2018 Oct 16. pii: 5133291. doi: 10.1093.
    PubMed     Abstract available


  102. TSANG RSW, Ahmad T, Jamieson FB, Tyrrell GJ, et al
    WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 beta-lactamase gene.
    J Antimicrob Chemother. 2018 Oct 8. pii: 5123547. doi: 10.1093.
    PubMed     Abstract available


  103. O'GRADY MC, Barry L, Corcoran GD, Hooton C, et al
    Empirical treatment of urinary tract infections: how rational are our guidelines?
    J Antimicrob Chemother. 2018 Oct 8. pii: 5123549. doi: 10.1093.
    PubMed     Abstract available


  104. KIM D, Park BY, Choi MH, Yoon EJ, et al
    Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection.
    J Antimicrob Chemother. 2018 Oct 5. pii: 5116214. doi: 10.1093.
    PubMed     Abstract available


  105. EILERTSON B, Chen L, Li A, Chavda KD, et al
    CG258 Klebsiella pneumoniae isolates without beta-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City.
    J Antimicrob Chemother. 2018 Oct 1. pii: 5113246. doi: 10.1093.
    PubMed     Abstract available


  106. TYSON GH, Sabo JL, Hoffmann M, Hsu CH, et al
    Novel linezolid resistance plasmids in Enterococcus from food animals in the USA.
    J Antimicrob Chemother. 2018 Oct 1. pii: 5106682. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  107. XHEMALI X, Smith JR, Kebriaei R, Rice SA, et al
    Evaluation of dalbavancin alone and in combination with beta-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Sep 27. pii: 5107805. doi: 10.1093.
    PubMed     Abstract available


  108. AUTMIZGUINE J, Smith PB, Prather K, Bendel C, et al
    Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
    J Antimicrob Chemother. 2018 Sep 20. pii: 5104445. doi: 10.1093.
    PubMed     Abstract available


  109. ZHOU X, Chlebowicz MA, Bathoorn E, Rosema S, et al
    Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.
    J Antimicrob Chemother. 2018 Sep 14. pii: 5096847. doi: 10.1093.
    PubMed     Abstract available


  110. SCHMIDT VM, Pinchbeck G, McIntyre KM, Nuttall T, et al
    Routine antibiotic therapy in dogs increases the detection of antimicrobial-resistant faecal Escherichia coli.
    J Antimicrob Chemother. 2018 Sep 11. pii: 5095201. doi: 10.1093.
    PubMed     Abstract available


  111. TAGG KA, Francois Watkins L, Moore MD, Bennett C, et al
    Novel trimethoprim resistance gene dfrA34 identified in Salmonella Heidelberg in the USA.
    J Antimicrob Chemother. 2018 Sep 10. pii: 5094565. doi: 10.1093.
    PubMed     Abstract available


  112. CABOT G, Florit-Mendoza L, Sanchez-Diener I, Zamorano L, et al
    Deciphering beta-lactamase-independent beta-lactam resistance evolution trajectories in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2018 Sep 5. pii: 5091007. doi: 10.1093.
    PubMed     Abstract available


  113. LEE RS, Goncalves da Silva A, Baines SL, Strachan J, et al
    The changing landscape of vancomycin-resistant Enterococcus faecium in Australia: a population-level genomic study.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090546. doi: 10.1093.
    PubMed     Abstract available


  114. JORGENSEN SCJ, McDonald P, Mynatt RP, Pogue JM, et al
    Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090540. doi: 10.1093.
    PubMed    


    August 2018
  115. CASELLA T, Haenni M, Madela NK, Andrade LK, et al
    Extended-spectrum cephalosporin-resistant Escherichia coli isolated from chickens and chicken meat in Brazil is associated with rare and complex resistance plasmids and pandemic ST lineages.
    J Antimicrob Chemother. 2018 Aug 31. pii: 5088381. doi: 10.1093.
    PubMed     Abstract available


  116. MACFADYEN AC, Harrison EM, Ellington MJ, Parkhill J, et al
    A highly conserved mecC-encoding SCCmec type XI in a bovine isolate of methicillin-resistant Staphylococcus xylosus.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5084893. doi: 10.1093.
    PubMed    


  117. CAMARA J, Cubero M, Martin-Galiano AJ, Garcia E, et al
    Evolution of the beta-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5079858. doi: 10.1093.
    PubMed     Abstract available


  118. DEWAN KK, Skarlupka AL, Rivera I, Cuff LE, et al
    Development of macrolide resistance in Bordetella bronchiseptica is associated with the loss of virulence.
    J Antimicrob Chemother. 2018 Aug 10. pii: 5069478. doi: 10.1093.
    PubMed     Abstract available


  119. HANSEN TA, Pedersen MS, Nielsen LG, Ma CMG, et al
    Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX.
    J Antimicrob Chemother. 2018 Aug 2. pii: 5064278. doi: 10.1093.
    PubMed     Abstract available


  120. BERKOW EL, Lockhart SR
    Activity of novel antifungal compound APX001A against a large collection of Candida auris.
    J Antimicrob Chemother. 2018 Aug 1. pii: 5063540. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  121. WILSON RE, Hill RLR, Chalker VJ, Mentasti M, et al
    Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
    J Antimicrob Chemother. 2018 Jul 24. pii: 5057980. doi: 10.1093.
    PubMed     Abstract available


  122. WIEDERHOLD NP, Locke JB, Daruwala P, Bartizal K, et al
    Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
    J Antimicrob Chemother. 2018 Jul 18. pii: 5055842. doi: 10.1093.
    PubMed     Abstract available


  123. MEYGRET A, Le Roy C, Renaudin H, Bebear C, et al
    Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015.
    J Antimicrob Chemother. 2018 Jul 6. pii: 5050099. doi: 10.1093.
    PubMed     Abstract available


  124. VELOO ACM, Chlebowicz M, Winter HLJ, Bathoorn D, et al
    Three metronidazole-resistant Prevotella bivia strains harbour a mobile element, encoding a novel nim gene, nimK, and an efflux small MDR transporter.
    J Antimicrob Chemother. 2018 Jul 2. pii: 5047838. doi: 10.1093.
    PubMed     Abstract available


  125. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  126. ADAM HJ, Golden AR, Karlowsky JA, Baxter MR, et al
    Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  127. ZHANEL GG, Adam HJ
    Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  128. KARLOWSKY JA, Adam HJ, Golden AR, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


    June 2018
  129. BARBER KE, Pogue JM, Warnock HD, Bonomo RA, et al
    Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2018 Jun 22. pii: 5043126. doi: 10.1093.
    PubMed     Abstract available


  130. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036449. doi: 10.1093.
    PubMed    


  131. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036451. doi: 10.1093.
    PubMed    


  132. TAVERNIER S, Sass A, De Bruyne M, Baeke F, et al
    Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036452. doi: 10.1093.
    PubMed     Abstract available


  133. ZONG Z, Fenn S, Connor C, Feng Y, et al
    Complete genomic characterization of two Escherichia coli lineages responsible for a cluster of carbapenem-resistant infections in a Chinese hospital.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035906. doi: 10.1093.
    PubMed     Abstract available


  134. FARKAS A, Sassine J, Mathew JP, Stavropoulos C, et al
    Outcomes associated with the use of a revised risk assessment strategy to predict antibiotic resistance in community-onset pneumonia: a stewardship perspective.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035907. doi: 10.1093.
    PubMed     Abstract available


  135. DESHPANDE LM, Castanheira M, Flamm RK, Mendes RE, et al
    Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    J Antimicrob Chemother. 2018 Jun 6. pii: 5033815. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  136. TALBOT JJ, Subedi S, Halliday CL, Hibbs DE, et al
    Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    J Antimicrob Chemother. 2018 May 29. pii: 5018389. doi: 10.1093.
    PubMed     Abstract available


  137. LIN JN, Lai CH, Yang CH, Huang YH, et al
    Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.
    J Antimicrob Chemother. 2018 May 28. pii: 5017392. doi: 10.1093.
    PubMed     Abstract available


  138. BREAK TJ, Desai JV, Healey KR, Natarajan M, et al
    VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
    J Antimicrob Chemother. 2018 May 16. pii: 4996888. doi: 10.1093.
    PubMed     Abstract available


  139. BACHIR M, Allem R, Benejat L, Tifrit A, et al
    Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
    J Antimicrob Chemother. 2018 May 11. pii: 4995220. doi: 10.1093.
    PubMed     Abstract available


  140. NYGAARD JENSEN J, Melander E, Hedin K, Bjerrum L, et al
    Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions.
    J Antimicrob Chemother. 2018 May 10. pii: 4995081. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  141. GUPTA P, Mankere B, Chekkoora Keloth S, Tuteja U, et al
    Increased antibiotic resistance exhibited by the biofilm of Vibrio cholerae O139.
    J Antimicrob Chemother. 2018 Apr 24. pii: 4984488. doi: 10.1093.
    PubMed     Abstract available


  142. SEUFERT R, Sedlacek L, Kahl B, Hogardt M, et al
    Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4978322. doi: 10.1093.
    PubMed     Abstract available


  143. SIMNER PJ, Antar AAR, Hao S, Gurtowski J, et al
    Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2018 Apr 10. pii: 4966148. doi: 10.1093.
    PubMed     Abstract available


  144. RIZZATO C, Poma N, Zoppo M, Posteraro B, et al
    CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates.
    J Antimicrob Chemother. 2018 Apr 9. pii: 4964989. doi: 10.1093.
    PubMed     Abstract available


  145. NAGU TJ, Aboud S, Matee MI, Maeurer MJ, et al
    Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study-authors' response.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960907. doi: 10.1093.
    PubMed    


  146. ANTONELLI A, D'Andrea MM, Brenciani A, Galeotti CL, et al
    Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960904. doi: 10.1093.
    PubMed     Abstract available


  147. HASHEMI MM, Rovig J, Holden BS, Taylor MF, et al
    Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960903. doi: 10.1093.
    PubMed     Abstract available


  148. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  149. TORUMKUNEY D, Papaparaskevas J, Morrissey I
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  150. TORUMKUNEY D, Zemlickova H, Maruscak M, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  151. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  152. TORUMKUNEY D, Mayanskiy N, Edelstein M, Sidorenko S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


    March 2018
  153. SCHNEIDER S, Salm F, Vincze S, Moeser A, et al
    Perceptions and attitudes regarding antibiotic resistance in Germany: a cross-sectoral survey amongst physicians, veterinarians, farmers and the general public.
    J Antimicrob Chemother. 2018 Mar 26. pii: 4953726. doi: 10.1093.
    PubMed     Abstract available


  154. WAREHAM DW, Phee LM, Abdul Momin MHF
    Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951547. doi: 10.1093.
    PubMed    


  155. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Abstract available


  156. PRICE L, Gozdzielewska L, Young M, Smith F, et al
    Effectiveness of interventions to improve the public's antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937884. doi: 10.1093.
    PubMed     Abstract available


  157. CARTER GP, Harjani JR, Li L, Pitcher NP, et al
    1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    J Antimicrob Chemother. 2018 Mar 6. pii: 4922693. doi: 10.1093.
    PubMed     Abstract available


  158. ASHLEY EA, Recht J, Chua A, Dance D, et al
    An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.
    J Antimicrob Chemother. 2018 Mar 5. pii: 4921008. doi: 10.1093.
    PubMed     Abstract available


  159. HAWKEY PM, Warren RE, Livermore DM, McNulty CAM, et al
    Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


    February 2018
  160. MCCARTY TP, Lockhart SR, Moser SA, Whiddon J, et al
    Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913721. doi: 10.1093.
    PubMed     Abstract available


  161. ROHDE AM, Wiese-Posselt M, Zweigner J, Schwab F, et al
    High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
    J Antimicrob Chemother. 2018 Feb 27. pii: 4911557. doi: 10.1093.
    PubMed     Abstract available


  162. HEMARAJATA P, Amick T, Yang S, Gregson A, et al
    Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    J Antimicrob Chemother. 2018 Feb 19. pii: 4877955. doi: 10.1093.
    PubMed     Abstract available


  163. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Abstract available


  164. DAMIAO GOUVEIA AC, Unemo M, Jensen JS
    In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains.
    J Antimicrob Chemother. 2018 Feb 12. pii: 4850948. doi: 10.1093.
    PubMed     Abstract available


  165. WESSELS C, Strommenger B, Klare I, Bender J, et al
    Emergence and control of linezolid-resistant Staphylococcus epidermidis in an ICU of a German hospital.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847818. doi: 10.1093.
    PubMed     Abstract available


  166. KAMBAREV S, Pecorari F, Corvec S
    Novel Tn916-like elements confer aminoglycoside/macrolide co-resistance in clinical isolates of Streptococcus gallolyticus ssp. gallolyticus.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847819. doi: 10.1093.
    PubMed     Abstract available


  167. SUN C, Zhang P, Ji X, Fan R, et al
    Presence and molecular characteristics of oxazolidinone resistance in staphylococci from household animals in rural China.
    J Antimicrob Chemother. 2018 Feb 7. pii: 4841776. doi: 10.1093.
    PubMed     Abstract available


  168. BIENVENU AL, Argaud L, Aubrun F, Fellahi JL, et al
    A systematic review of interventions and performance measures for antifungal stewardship programmes.
    J Antimicrob Chemother. 2018;73:297-305.
    PubMed     Abstract available


  169. ITO R, Pacey MP, Mettus RT, Sluis-Cremer N, et al
    Origin of the plasmid-mediated fosfomycin resistance gene fosA3.
    J Antimicrob Chemother. 2018;73:373-376.
    PubMed     Abstract available


  170. GAROFF L, Yadav K, Hughes D
    Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli.
    J Antimicrob Chemother. 2018;73:348-352.
    PubMed     Abstract available


  171. DINGSDAG SA, Hunter N
    Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms.
    J Antimicrob Chemother. 2018;73:265-279.
    PubMed     Abstract available


  172. SEANG S, Schneider L, Nguyen T, Le MP, et al
    Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.
    J Antimicrob Chemother. 2018;73:490-493.
    PubMed     Abstract available


  173. HAENNI M, Beyrouthy R, Lupo A, Chatre P, et al
    Epidemic spread of Escherichia coli ST744 isolates carrying mcr-3 and blaCTX-M-55 in cattle in France.
    J Antimicrob Chemother. 2018;73:533-536.
    PubMed    


  174. JAYOL A, Nordmann P, Poirel L, Dubois V, et al
    Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2018;73:542-544.
    PubMed    


  175. NEVES FPG, Cardoso NT, Souza ARV, Snyder RE, et al
    Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.
    J Antimicrob Chemother. 2018 Feb 1. pii: 4833983. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  176. POUWELS KB, Freeman R, Muller-Pebody B, Rooney G, et al
    Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4832009. doi: 10.1093.
    PubMed     Abstract available


  177. LESTRADE PP, van der Velden WJFM, Bouwman F, Stoop FJ, et al
    Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4831957. doi: 10.1093.
    PubMed     Abstract available


  178. BRYCE A, Costelloe C, Wootton M, Butler CC, et al
    Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study.
    J Antimicrob Chemother. 2018 Jan 29. pii: 4828185. doi: 10.1093.
    PubMed     Abstract available


  179. PARTRIDGE SR, Tsafnat G
    Automated annotation of mobile antibiotic resistance in Gram-negative bacteria: the Multiple Antibiotic Resistance Annotator (MARA) and database.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823430. doi: 10.1093.
    PubMed     Abstract available


  180. XIE M, Li R, Liu Z, Chan EWC, et al
    Recombination of plasmids in a carbapenem-resistant NDM-5-producing clinical Escherichia coli isolate.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823432. doi: 10.1093.
    PubMed     Abstract available


  181. ROZWANDOWICZ M, Brouwer MSM, Fischer J, Wagenaar JA, et al
    Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4822282. doi: 10.1093.
    PubMed     Abstract available


  182. TEBANO G, la Martire G, Sarmento N, Francis JR, et al
    Antibiotic resistance in Timor-Leste: a systematic review of evidence.
    J Antimicrob Chemother. 2018 Jan 22. pii: 4819241. doi: 10.1093.
    PubMed    


  183. BASUINO L, Jousselin A, Alexander JAN, Strynadka NCJ, et al
    PBP4 activity and its overexpression are necessary for PBP4-mediated high-level beta-lactam resistance.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817624. doi: 10.1093.
    PubMed     Abstract available


  184. DOOKIE N, Rambaran S, Padayatchi N, Mahomed S, et al
    Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817621. doi: 10.1093.
    PubMed     Abstract available


  185. HAENSSGEN MJ, Charoenboon N, Khine Zaw Y
    It is time to give social research a voice to tackle antimicrobial resistance?
    J Antimicrob Chemother. 2018 Jan 18. pii: 4817296. doi: 10.1093.
    PubMed    


  186. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Abstract available


  187. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Abstract available


  188. CHOWDHARY A, Prakash A, Sharma C, Kordalewska M, et al
    A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4794718. doi: 10.1093.
    PubMed     Abstract available


  189. CESARO S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, et al
    ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.
    J Antimicrob Chemother. 2018;73:12-21.
    PubMed     Abstract available


  190. ZHOU K, Yu W, Cao X, Shen P, et al
    Characterization of the population structure, drug resistance mechanisms and plasmids of the community-associated Enterobacter cloacae complex in China.
    J Antimicrob Chemother. 2018;73:66-76.
    PubMed     Abstract available


  191. CASTAGNA A, Ferrara M, Galli L, Comi L, et al
    Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.
    J Antimicrob Chemother. 2018;73:177-182.
    PubMed     Abstract available


  192. PERRIER M, Visseaux B, Landman R, Joly V, et al
    No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
    J Antimicrob Chemother. 2018;73:173-176.
    PubMed     Abstract available


  193. KENGKLA K, Kongpakwattana K, Saokaew S, Apisarnthanarak A, et al
    Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.
    J Antimicrob Chemother. 2018;73:22-32.
    PubMed     Abstract available


  194. HEIDARY M, Khosravi AD, Khoshnood S, Nasiri MJ, et al
    Daptomycin.
    J Antimicrob Chemother. 2018;73:1-11.
    PubMed     Abstract available


  195. LIVERMORE DM, Mushtaq S, Warner M, Turner SJ, et al
    Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogens.
    J Antimicrob Chemother. 2018;73:126-133.
    PubMed     Abstract available


  196. MALCOLM W, Fletcher E, Kavanagh K, Deshpande A, et al
    Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform.
    J Antimicrob Chemother. 2018;73:223-230.
    PubMed     Abstract available


  197. JIN L, Wang R, Wang X, Wang Q, et al
    Emergence of mcr-1 and carbapenemase genes in hospital sewage water in Beijing, China.
    J Antimicrob Chemother. 2018;73:84-87.
    PubMed     Abstract available


  198. THAKUR SD, Levett PN, Horsman GB, Dillon JR, et al
    High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
    J Antimicrob Chemother. 2018;73:118-125.
    PubMed     Abstract available


  199. LI Y, Li Y, Fernandez Crespo R, Leanse LG, et al
    Characterization of the Actinobacillus pleuropneumoniae SXT-related integrative and conjugative element ICEApl2 and analysis of the encoded FloR protein: hydrophobic residues in transmembrane domains contribute dynamically to florfenicol and chloramph
    J Antimicrob Chemother. 2018;73:57-65.
    PubMed     Abstract available


  200. LAI MT, Tawa P, Auger A, Wang D, et al
    Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors.
    J Antimicrob Chemother. 2018;73:109-117.
    PubMed     Abstract available


  201. BOTELHO J, Grosso F, Peixe L
    Unravelling the genome of a Pseudomonas aeruginosa isolate belonging to the high-risk clone ST235 reveals an integrative conjugative element housing a blaGES-6 carbapenemase.
    J Antimicrob Chemother. 2018;73:77-83.
    PubMed     Abstract available


  202. BASSETTI M, Righi E, Montravers P, Cornely OA, et al
    What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


  203. LAMOTH F, Lockhart SR, Berkow EL, Calandra T, et al
    Changes in the epidemiological landscape of invasive candidiasis.
    J Antimicrob Chemother. 2018;73.
    PubMed     Abstract available


    December 2017
  204. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Abstract available


  205. DECROO T, Van Deun A, Lynen L
    Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774628. doi: 10.1093.
    PubMed    


  206. KLOTZ P, Jacobmeyer L, Stamm I, Leidner U, et al
    Carbapenem-resistant Acinetobacter baumannii ST294 harbouring the OXA-72 carbapenemase from a captive grey parrot.
    J Antimicrob Chemother. 2017 Dec 21. pii: 4772354. doi: 10.1093.
    PubMed    


  207. BERGLUND B, Hoang NTB, Tarnberg M, Le NK, et al
    Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam.
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748887. doi: 10.1093.
    PubMed    


  208. WOODFORD N, Xu-McCrae L, Mushtaq S, Wu HHT, et al
    Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748884. doi: 10.1093.
    PubMed     Abstract available


  209. CASPAR Y, Hennebique A, Maurin M
    Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745834. doi: 10.1093.
    PubMed     Abstract available


  210. HARRIS PNA, Ben Zakour NL, Roberts LW, Wailan AM, et al
    Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745835. doi: 10.1093.
    PubMed     Abstract available


  211. EDSLEV SM, Clausen ML, Agner T, Stegger M, et al
    Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745837. doi: 10.1093.
    PubMed     Abstract available


  212. DAY MR, Doumith M, Do Nascimento V, Nair S, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693726. doi: 10.1093.
    PubMed     Abstract available


  213. CHEN C, Hooper DC
    Effect of Staphylococcus aureus Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess model.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693732. doi: 10.1093.
    PubMed     Abstract available


    November 2017
  214. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Abstract available


  215. FJALSTAD JW, Esaiassen E, Juvet LK, van den Anker JN, et al
    Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4652876. doi: 10.1093.
    PubMed     Abstract available


  216. LEE RS, Seemann T, Heffernan H, Kwong JC, et al
    Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4647718. doi: 10.1093.
    PubMed     Abstract available


  217. CAI Y, Yang D, Wang J, Wang R, et al
    Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Abstract available


  218. FREITAS AR, Tedim AP, Novais C, Coque TM, et al
    Distribution of putative virulence markers in Enterococcus faecium: towards a safety profile review.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Abstract available


  219. MARQUES C, Belas A, Franco A, Aboim C, et al
    Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed     Abstract available


  220. KOSHKOLDA T, Luck C
    Antibiotic susceptibility of clinical Legionella pneumophila serogroup 1 strains isolated in Germany.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed    


    October 2017
  221. DORTET L, Glaser P, Kassis-Chikhani N, Girlich D, et al
    Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Abstract available


  222. VYAZOVAYA A, Levina K, Zhuravlev V, Viiklepp P, et al
    Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Abstract available


  223. CHEN CJ, Lauderdale TY, Lu CT, Chuang YY, et al
    Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Abstract available


  224. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Abstract available


  225. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed    


  226. BREAK TJ, Desai JV, Natarajan M, Ferre EMN, et al
    VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Abstract available


  227. JIMENEZ-CASTELLANOS JC, Wan Nur Ismah WAK, Takebayashi Y, Findlay J, et al
    Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired beta-lactam resistance.
    J Antimicrob Chemother. 2017 Oct 6. doi: 10.1093.
    PubMed     Abstract available


  228. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries-authors' response.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed    


  229. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Abstract available


  230. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Abstract available


  231. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Abstract available


  232. ZANKARI E, Allesoe R, Joensen KG, Cavaco LM, et al
    PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens.
    J Antimicrob Chemother. 2017;72:2764-2768.
    PubMed     Abstract available


  233. OVIANO M, Gomara M, Barba MJ, Sparbier K, et al
    Quantitative and automated MALDI-TOF MS-based detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2952-2954.
    PubMed    


  234. LEE MC, Sun PL, Wu TL, Wang LH, et al
    Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    J Antimicrob Chemother. 2017;72:2782-2786.
    PubMed     Abstract available


  235. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Abstract available


  236. WEBBER MA, Buckner MMC, Redgrave LS, Ifill G, et al
    Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan.
    J Antimicrob Chemother. 2017;72:2755-2763.
    PubMed     Abstract available


  237. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Abstract available


  238. YEW WW, Liang D, Chan DP, Shi W, et al
    Molecular mechanisms of clofazimine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017;72:2943-2944.
    PubMed    


    September 2017
  239. ARANA DM, Ortega A, Gonzalez-Barbera E, Lara N, et al
    Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed     Abstract available


  240. ZHANG Q, Hua X, Ruan Z, Yu Y, et al
    Revisiting the contribution of gene duplication of blaOXA-23 in carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed    


  241. FREITAS AR, Elghaieb H, Leon-Sampedro R, Abbassi MS, et al
    Detection of optrA in the African continent (Tunisia) within a mosaic Enterococcus faecalis plasmid from urban wastewaters.
    J Antimicrob Chemother. 2017 Sep 26. doi: 10.1093.
    PubMed     Abstract available


  242. PULCINI C
    Comment on: National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Sep 18. doi: 10.1093.
    PubMed    


  243. CHEN J, Zhang S, Cui P, Shi W, et al
    Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Sep 12. doi: 10.1093.
    PubMed     Abstract available


  244. DO NASCIMENTO V, Day MR, Doumith M, Hopkins KL, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of enteroaggregative Escherichia coli isolated from cases of diarrhoeal disease in England, 2015-16.
    J Antimicrob Chemother. 2017 Sep 11. doi: 10.1093.
    PubMed     Abstract available


  245. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Abstract available


  246. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  247. LEE GC, Dallas SD, Wang Y, Olsen RJ, et al
    Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization.
    J Antimicrob Chemother. 2017;72:2461-2468.
    PubMed     Abstract available


    August 2017
  248. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Abstract available


  249. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Abstract available


  250. ATKINSON CT, Kunde DA, Tristram SG
    Expression of acquired macrolide resistance genes in Haemophilus influenzae.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Abstract available


  251. PRASKI ALZRIGAT L, Huseby DL, Brandis G, Hughes D, et al
    Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Abstract available


  252. NIGRO SJ, Hall RM
    A large plasmid, pD46-4, carrying a complex resistance region in an extensively antibiotic-resistant ST25 Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Aug 14. doi: 10.1093.
    PubMed    


  253. HOMBACH M, Jetter M, Keller PM, Blochliger N, et al
    Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Abstract available


  254. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Abstract available


  255. ZELLWEGER RM, Carrique-Mas J, Limmathurotsakul D, Day NPJ, et al
    A current perspective on antimicrobial resistance in Southeast Asia.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Abstract available


  256. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Abstract available


  257. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Abstract available


  258. ROMINSKI A, Selchow P, Becker K, Brulle JK, et al
    Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes.
    J Antimicrob Chemother. 2017;72:2191-2200.
    PubMed     Abstract available


  259. BRENNER BG, Ibanescu RI, Oliveira M, Roger M, et al
    HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.
    J Antimicrob Chemother. 2017;72:2171-2183.
    PubMed     Abstract available


  260. SOULIE C, Grude M, Descamps D, Amiel C, et al
    Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
    J Antimicrob Chemother. 2017;72:2351-2354.
    PubMed     Abstract available


  261. OVIANO M, Gomara M, Barba MJ, Revillo MJ, et al
    Towards the early detection of beta-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis.
    J Antimicrob Chemother. 2017;72:2259-2262.
    PubMed     Abstract available


    July 2017
  262. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Abstract available


  263. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Jul 25. doi: 10.1093.
    PubMed     Abstract available


  264. KWON HI, Kim S, Oh MH, Na SH, et al
    Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain.
    J Antimicrob Chemother. 2017 Jul 24. doi: 10.1093.
    PubMed     Abstract available


    June 2017
  265. HAMIDIAN M, Hall RM
    Origin of the AbGRI1 antibiotic resistance island found in the comM gene of Acinetobacter baumannii GC2 isolates.
    J Antimicrob Chemother. 2017 Jun 28. doi: 10.1093.
    PubMed    


  266. DI SANTE L, Morroni G, Brenciani A, Vignaroli C, et al
    pHTbeta-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis.
    J Antimicrob Chemother. 2017 Jun 22. doi: 10.1093.
    PubMed     Abstract available


  267. VOURLI S, Dafopoulou K, Vrioni G, Tsakris A, et al
    Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Abstract available


  268. TOMASO H, Hotzel H, Otto P, Myrtennas K, et al
    Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Abstract available


  269. BUIL JB, Rijs AJMM, Meis JF, Birch M, et al
    In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    J Antimicrob Chemother. 2017 Jun 10. doi: 10.1093.
    PubMed     Abstract available


  270. POWELL N, Davidson I, Yelling P, Collinson A, et al
    Developing a local antimicrobial resistance action plan: the Cornwall One Health Antimicrobial Resistance Group.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Abstract available


  271. SADOUKI Z, Day MR, Doumith M, Chattaway MA, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Shigella sonnei isolated from cases of diarrhoeal disease in England and Wales, 2015.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Abstract available


  272. STANCZAK-MROZEK KI, Laing KG, Lindsay JA
    Resistance gene transfer: induction of transducing phage by sub-inhibitory concentrations of antimicrobials is not correlated to induction of lytic phage.
    J Antimicrob Chemother. 2017;72:1624-1631.
    PubMed     Abstract available


  273. MUSICHA P, Feasey NA, Cain AK, Kallonen T, et al
    Genomic landscape of extended-spectrum beta-lactamase resistance in Escherichia coli from an urban African setting.
    J Antimicrob Chemother. 2017;72:1602-1609.
    PubMed     Abstract available


  274. MUSHTAQ S, Vickers A, Woodford N, Livermore DM, et al
    WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D beta-lactamases.
    J Antimicrob Chemother. 2017;72:1688-1695.
    PubMed     Abstract available


  275. ANDRADE SD, Sabido M, Monteiro WM, Benzaken AS, et al
    Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    J Antimicrob Chemother. 2017;72:1774-1783.
    PubMed     Abstract available


  276. HOBBS MR, Grant CC, Ritchie SR, Chelimo C, et al
    Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5 years.
    J Antimicrob Chemother. 2017;72:1832-1840.
    PubMed     Abstract available


  277. BRETAGNE S, Renaudat C, Desnos-Ollivier M, Sitbon K, et al
    Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
    J Antimicrob Chemother. 2017;72:1784-1793.
    PubMed     Abstract available


  278. ASSOUMOU L, Charpentier C, Recordon-Pinson P, Grude M, et al
    Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
    J Antimicrob Chemother. 2017;72:1769-1773.
    PubMed     Abstract available


  279. ZHOU YF, Tao MT, Feng Y, Yang RS, et al
    Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
    J Antimicrob Chemother. 2017;72:1723-1730.
    PubMed     Abstract available


  280. NISHIKAWA H, Fukuda Y, Mitsuyama J, Tashiro M, et al
    In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    J Antimicrob Chemother. 2017;72:1709-1713.
    PubMed     Abstract available


  281. TANG Y, Dai L, Sahin O, Wu Z, et al
    Emergence of a plasmid-borne multidrug resistance gene cfr(C) in foodborne pathogen Campylobacter.
    J Antimicrob Chemother. 2017;72:1581-1588.
    PubMed     Abstract available


  282. KAUSHIK A, Ammerman NC, Tasneen R, Story-Roller E, et al
    In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Abstract available


  283. HURST SF, Berkow EL, Stevenson KL, Litvintseva AP, et al
    Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Abstract available


    May 2017
  284. ALAUZET C, Berger S, Jean-Pierre H, Dubreuil L, et al
    nimH, a novel nitroimidazole resistance gene contributing to metronidazole resistance in Bacteroides fragilis.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed    


  285. SHU JC, Kuo AJ, Su LH, Liu TP, et al
    Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Abstract available


  286. AMBROSIONI J, Mosquera MM, Miro JM
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection-authors' response.
    J Antimicrob Chemother. 2017;72:1547-1548.
    PubMed    


  287. FABRIZIO C, Lepore L, Lagioia A, Punzi G, et al
    Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:1546-1547.
    PubMed    


  288. PFALLER MA, Bassetti M, Duncan LR, Castanheira M, et al
    Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
    J Antimicrob Chemother. 2017;72:1386-1395.
    PubMed     Abstract available


  289. GOODALL RL, Dunn DT, Nkurunziza P, Mugarura L, et al
    Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
    J Antimicrob Chemother. 2017;72:1450-1455.
    PubMed     Abstract available


  290. TAM VH, Chang KT, Zhou J, Ledesma KR, et al
    Determining beta-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.
    J Antimicrob Chemother. 2017;72:1421-1428.
    PubMed     Abstract available


  291. GUENTHER S, Falgenhauer L, Semmler T, Imirzalioglu C, et al
    Environmental emission of multiresistant Escherichia coli carrying the colistin resistance gene mcr-1 from German swine farms.
    J Antimicrob Chemother. 2017;72:1289-1292.
    PubMed     Abstract available


  292. DUPRILOT M, Decre D, Genel N, Drieux L, et al
    Diversity and functionality of plasmid-borne VagCD toxin-antitoxin systems of Klebsiella pneumoniae.
    J Antimicrob Chemother. 2017;72:1320-1326.
    PubMed     Abstract available


  293. ROUKENS M, Verhoef L, Stobberingh E, Natsch S, et al
    Surveillance of antimicrobial use in Dutch long-term care facilities.
    J Antimicrob Chemother. 2017;72:1516-1520.
    PubMed     Abstract available


  294. BALLESTERO-TELLEZ M, Docobo-Perez F, Portillo-Calderon I, Rodriguez-Martinez JM, et al
    Molecular insights into fosfomycin resistance in Escherichia coli.
    J Antimicrob Chemother. 2017;72:1303-1309.
    PubMed     Abstract available


  295. LANGE F, Pfennigwerth N, Gerigk S, Gohlke F, et al
    Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany.
    J Antimicrob Chemother. 2017;72:1334-1339.
    PubMed     Abstract available


  296. VAN EIJK E, Wittekoek B, Kuijper EJ, Smits WK, et al
    DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2017;72:1275-1284.
    PubMed     Abstract available


    April 2017
  297. EHRMANN E, Jolivet-Gougeon A, Bonnaure-Mallet M, Fosse T, et al
    Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    J Antimicrob Chemother. 2017 Apr 26. doi: 10.1093.
    PubMed     Abstract available


  298. ZIMENKOV DV, Nosova EY, Kulagina EV, Antonova OV, et al
    Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    J Antimicrob Chemother. 2017 Apr 6. doi: 10.1093.
    PubMed     Abstract available


  299. OVEJERO CM, Delgado-Blas JF, Calero-Caceres W, Muniesa M, et al
    Spread of mcr-1-carrying Enterobacteriaceae in sewage water from Spain.
    J Antimicrob Chemother. 2017;72:1050-1053.
    PubMed     Abstract available


  300. PFENNIGWERTH N, Lange F, Belmar Campos C, Hentschke M, et al
    Genetic and biochemical characterization of HMB-1, a novel subclass B1 metallo-beta-lactamase found in a Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2017;72:1068-1073.
    PubMed     Abstract available


  301. CROSS EL, Tolfree R, Kipping R
    Systematic review of public-targeted communication interventions to improve antibiotic use.
    J Antimicrob Chemother. 2017;72:975-987.
    PubMed     Abstract available


  302. WATTAL C, Chakrabarti A, Oberoi JK, Donnelly JP, et al
    Issues in antifungal stewardship: an opportunity that should not be lost.
    J Antimicrob Chemother. 2017;72:969-974.
    PubMed     Abstract available


  303. JOHNSON AP, Muller-Pebody B, Budd E, Ashiru-Oredope D, et al
    Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips.
    J Antimicrob Chemother. 2017;72:953-956.
    PubMed     Abstract available


  304. CHAPMAN B, Slavin M, Marriott D, Halliday C, et al
    Changing epidemiology of candidaemia in Australia.
    J Antimicrob Chemother. 2017;72:1103-1108.
    PubMed     Abstract available


  305. MADELAIN V, Le MP, Champenois K, Charpentier C, et al
    Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
    J Antimicrob Chemother. 2017;72:1137-1146.
    PubMed     Abstract available


  306. SOUSA DOMINGUEZ A, Perez-Rodriguez MT, Nodar A, Martinez-Lamas L, et al
    Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
    J Antimicrob Chemother. 2017;72:1262-1263.
    PubMed    


    March 2017
  307. SAN-JUAN R, Fernandez-Ruiz M, Gasch O, Camoez M, et al
    High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Mar 31. doi: 10.1093.
    PubMed     Abstract available


  308. FALAGAS ME, Skalidis T, Vardakas KZ, Legakis NJ, et al
    Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Abstract available


  309. ROER L, Hansen F, Thomsen MC, Knudsen JD, et al
    WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Abstract available


  310. HAMIDIAN M, Nigro SJ, Hartstein RM, Hall RM, et al
    RCH51, a multiply antibiotic-resistant Acinetobacter baumannii ST103IP isolate, carries resistance genes in three plasmids, including a novel potentially conjugative plasmid carrying oxa235 in transposon Tn6252.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Abstract available


  311. HAWKINS PA, Law CS, Metcalf BJ, Chochua S, et al
    Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Abstract available


  312. JAGANATH D, Schaaf HS, Donald PR
    Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.
    J Antimicrob Chemother. 2017 Mar 9. doi: 10.1093.
    PubMed     Abstract available


  313. GRONTHAL T, Eklund M, Thomson K, Piiparinen H, et al
    Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland.
    J Antimicrob Chemother. 2017 Mar 8. doi: 10.1093.
    PubMed    


  314. DE LASTOURS V, Maugy E, Mathy V, Chau F, et al
    Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
    J Antimicrob Chemother. 2017 Mar 4. doi: 10.1093.
    PubMed     Abstract available


  315. LASS-FLORL C, Cuenca-Estrella M
    Changes in the epidemiological landscape of invasive mould infections and disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Abstract available


  316. STEFIC K, Salmona M, Capitao M, Splittgerber M, et al
    Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.
    J Antimicrob Chemother. 2017;72:850-854.
    PubMed     Abstract available


  317. SULLY EK, Geller BL, Li L, Moody CM, et al
    Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
    J Antimicrob Chemother. 2017;72:782-790.
    PubMed     Abstract available


  318. KLETENKOV K, Hoffmann D, Boni J, Yerly S, et al
    Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
    J Antimicrob Chemother. 2017;72:866-875.
    PubMed     Abstract available


  319. DUGGETT NA, Sayers E, AbuOun M, Ellis RJ, et al
    Occurrence and characterization of mcr-1-harbouring Escherichia coli isolated from pigs in Great Britain from 2013 to 2015.
    J Antimicrob Chemother. 2017;72:691-695.
    PubMed     Abstract available


  320. BRIAND C, Dollfus C, Faye A, Kantor E, et al
    Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
    J Antimicrob Chemother. 2017;72:837-843.
    PubMed     Abstract available


    February 2017
  321. LENHARD JR, Thamlikitkul V, Silveira FP, Garonzik SM, et al
    Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Abstract available


  322. MOUGARI F, Loiseau J, Veziris N, Bernard C, et al
    Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Abstract available


  323. CAVANAUGH JS, Jou R, Wu MH, Dalton T, et al
    Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    J Antimicrob Chemother. 2017 Feb 20. doi: 10.1093.
    PubMed     Abstract available


  324. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study.
    J Antimicrob Chemother. 2017 Feb 17. doi: 10.1093.
    PubMed     Abstract available


  325. BOIKOV DA, Locke JB, James KD, Bartizal K, et al
    In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    J Antimicrob Chemother. 2017 Feb 3. doi: 10.1093.
    PubMed    


  326. LI R, Xie M, Zhang J, Yang Z, et al
    Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant.
    J Antimicrob Chemother. 2017;72:393-401.
    PubMed     Abstract available


  327. BOERMA RS, Sigaloff KC, Akanmu AS, Inzaule S, et al
    Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2017;72:365-371.
    PubMed     Abstract available


  328. ZAHEDI BIALVAEI A, Rahbar M, Yousefi M, Asgharzadeh M, et al
    Linezolid: a promising option in the treatment of Gram-positives.
    J Antimicrob Chemother. 2017;72:354-364.
    PubMed     Abstract available


  329. ROMINSKI A, Roditscheff A, Selchow P, Bottger EC, et al
    Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.
    J Antimicrob Chemother. 2017;72:376-384.
    PubMed     Abstract available


  330. BEYROUTHY R, Robin F, Hamze M, Bonnet R, et al
    IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2.
    J Antimicrob Chemother. 2017;72:402-406.
    PubMed     Abstract available


  331. PADGET M, Tamarelle J, Herindrainy P, Ndir A, et al
    A community survey of antibiotic consumption among children in Madagascar and Senegal: the importance of healthcare access and care quality.
    J Antimicrob Chemother. 2017;72:564-573.
    PubMed     Abstract available


  332. GONZALEZ-SERNA A, Glas AC, Brumme CJ, Poon AF, et al
    Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.
    J Antimicrob Chemother. 2017;72:496-503.
    PubMed     Abstract available


  333. TAN C, Vermeulen M, Wang X, Zvonar R, et al
    Variability in antibiotic use across Ontario acute care hospitals.
    J Antimicrob Chemother. 2017;72:554-563.
    PubMed     Abstract available


  334. BAILEY C, Tully MP, Pampaka M, Cooke J, et al
    Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17).
    J Antimicrob Chemother. 2017;72:604-613.
    PubMed     Abstract available


  335. NY S, Lofmark S, Borjesson S, Englund S, et al
    Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study.
    J Antimicrob Chemother. 2017;72:582-588.
    PubMed     Abstract available


  336. BISSIO E, Barbas MG, Bouzas MB, Cudola A, et al
    Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.
    J Antimicrob Chemother. 2017;72:504-510.
    PubMed     Abstract available


  337. SADAHIRA T, Wada K, Araki M, Ishii A, et al
    Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
    J Antimicrob Chemother. 2017;72:529-534.
    PubMed     Abstract available


  338. TREPANIER P, Mallard K, Meunier D, Pike R, et al
    Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    J Antimicrob Chemother. 2017;72:596-603.
    PubMed     Abstract available


  339. CABELLO FC, Godfrey HP
    Comment on: Transferable resistance to colistin: a new but old threat.
    J Antimicrob Chemother. 2017;72:636-637.
    PubMed    


    January 2017
  340. LEDDA A, Price JR, Cole K, Llewelyn MJ, et al
    Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Jan 20. pii: dkw570. doi: 10.1093.
    PubMed     Abstract available


  341. STONE GG, Bradford PA, Yates K, Newell P, et al
    In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.
    J Antimicrob Chemother. 2017 Jan 14. pii: dkw561. doi: 10.1093.
    PubMed     Abstract available


  342. XISTO MI, Caramalho RD, Rocha DA, Ferreira-Pereira A, et al
    Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw558. doi: 10.1093.
    PubMed     Abstract available


  343. OTSUKA T, Brauer AL, Kirkham C, Sully EK, et al
    Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.
    J Antimicrob Chemother. 2017;72:137-144.
    PubMed     Abstract available


  344. CUNNINGHAM E, Chan YT, Aghaizu A, Bibby DF, et al
    Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.
    J Antimicrob Chemother. 2017;72:227-234.
    PubMed     Abstract available


  345. DEGHMANE AE, Hong E, Taha MK
    Emergence of meningococci with reduced susceptibility to third-generation cephalosporins.
    J Antimicrob Chemother. 2017;72:95-98.
    PubMed     Abstract available


  346. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
    J Antimicrob Chemother. 2017;72:210-219.
    PubMed     Abstract available


  347. SHARMA A, Sharma R, Bhattacharyya T, Bhando T, et al
    Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter-AbaF.
    J Antimicrob Chemother. 2017;72:68-74.
    PubMed     Abstract available


  348. AMBROSIONI J, Nicolas D, Manzardo C, Aguero F, et al
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:205-209.
    PubMed     Abstract available


    December 2016
  349. ZHU XQ, Wang XM, Li H, Shang YH, et al
    Novel lnu(G) gene conferring resistance to lincomycin by nucleotidylation, located on Tn6260 from Enterococcus faecalis E531.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw549. doi: 10.1093.
    PubMed     Abstract available


  350. BUTIN M, Martins-Simoes P, Pichon B, Leyssene D, et al
    Emergence and dissemination of a linezolid-resistant Staphylococcus capitis clone in Europe.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw516. doi: 10.1093.
    PubMed     Abstract available


  351. BRITT NS, Patel N, Shireman TI, El Atrouni WI, et al
    Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw453. doi: 10.1093.
    PubMed     Abstract available


  352. CAVACO LM, Bernal JF, Zankari E, Leon M, et al
    Detection of linezolid resistance due to the optrA gene in Enterococcus faecalis from poultry meat from the American continent (Colombia).
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw490. doi: 10.1093.
    PubMed     Abstract available


  353. TANIGUCHI R, Kimura K, Miyazaki A, Banno H, et al
    High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw500. doi: 10.1093.
    PubMed    


    November 2016
  354. SWEENEY D, Stoneburner A, Shinabarger DL, Arhin FF, et al
    Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2016.
    PubMed    


    September 2016
  355. MULDER M, Kiefte-de Jong JC, Goessens WH, de Visser H, et al
    Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  356. KUBICEK-SUTHERLAND JZ, Lofton H, Vestergaard M, Hjort K, et al
    Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  357. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  358. MORICI E, Simoni S, Brenciani A, Giovanetti E, et al
    A new mosaic integrative and conjugative element from Streptococcus agalactiae carrying resistance genes for chloramphenicol (catQ) and macrolides [mef(I) and erm(TR)].
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  359. MENDES RE, Castanheira M, Farrell DJ, Flamm RK, et al
    Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


    August 2016
  360. CHONG GM, van der Beek MT, von dem Borne PA, Boelens J, et al
    PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay(R) in 201 patients with haematological disease suspected for invasive aspergillosis.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  361. LAHIRI SD, Alm RA
    Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  362. VERWEIJ PE, Lestrade PP, Melchers WJ, Meis JF, et al
    Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?
    J Antimicrob Chemother. 2016;71:2079-82.
    PubMed     Abstract available


  363. ALANIO A, Denis B, Hamane S, Raffoux E, et al
    New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?
    J Antimicrob Chemother. 2016;71:2075-8.
    PubMed     Abstract available


    July 2016
  364. TSAO S, Weber S, Cameron C, Nehme D, et al
    Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


    June 2016
  365. SINEL C, Cosquer T, Auzou M, Goux D, et al
    Sequential steps of daptomycin resistance in Enterococcus faecium and reversion to hypersusceptibility through IS-mediated inactivation of the liaFSR operon.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  366. PFALLER MA, Messer SA, Rhomberg PR, Jones RN, et al
    Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  367. EILERTSON B, Maruri F, Blackman A, Guo Y, et al
    A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


    May 2016
  368. SEROY JT, Grim SA, Reid GE, Wellington T, et al
    Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  369. PANTEL A, Petrella S, Veziris N, Matrat S, et al
    Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


  370. LIU P, Xue H, Wu Z, Ma J, et al
    Effect of bla regulators on the susceptible phenotype and phenotypic conversion for oxacillin-susceptible mecA-positive staphylococcal isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


    April 2016
  371. DEPLANO A, Vandendriessche S, Nonhoff C, Dodemont M, et al
    National surveillance of Staphylococcus epidermidis recovered from bloodstream infections in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


    March 2016
  372. LIN YT, Tsai JC, Yamamoto T, Chen HJ, et al
    Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
    J Antimicrob Chemother. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: